Growth Metrics

Bio-Techne (TECH) Change in Receivables (2016 - 2026)

Bio-Techne has reported Change in Receivables over the past 17 years, most recently at -$941000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables fell 251.04% year-over-year to -$941000.0; the TTM value through Dec 2025 reached -$36.5 million, down 283.3%, while the annual FY2025 figure was -$34.1 million, 266.23% down from the prior year.
  • Change in Receivables for Q4 2025 was -$941000.0 at Bio-Techne, up from -$22.4 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $51.6 million in Q1 2022 and troughed at -$28.9 million in Q2 2025.
  • A 5-year average of $2.7 million and a median of $357500.0 in 2023 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: crashed 576.63% in 2022 and later soared 19380.43% in 2024.
  • Year by year, Change in Receivables stood at $5.7 million in 2021, then increased by 3.5% to $5.9 million in 2022, then crashed by 180.1% to -$4.7 million in 2023, then soared by 113.16% to $623000.0 in 2024, then plummeted by 251.04% to -$941000.0 in 2025.
  • Business Quant data shows Change in Receivables for TECH at -$941000.0 in Q4 2025, -$22.4 million in Q3 2025, and -$28.9 million in Q2 2025.